Security key
31447P100
FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (FENC)
CUSIP: 31447P100
Q4 2018 13F Holders as of 31 Dec 2018
- Security type / class
- Equity / Common Shares, no par value
- Total 13F shares
- 9,742,725
- Total 13F value
- $62,159,250
- Share change
- +307,850
- SEC-reported price per share
- $6.38
- Number of holders
- 45
- Value change
- +$1,863,710
- Number of buys
- 20
- Number of sells
- 17
- Shares outstanding
- 34,474,972
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2018
Institutions
45
Top holders
10
FENC full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2019
Previous quarter: Q3 2018
FENNEC PHARMACEUTICALS INC. SEC filings
FENNEC PHARMACEUTICALS INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 31447P100
Recent filing periods:
Ownership snapshot
Top reported holders of FENC - FENNEC PHARMACEUTICALS INC. - Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Southpoint Capital Adviso...
Disclosed value leader
Southpoint Capital Adviso...
Comparable rows
15/15
Latest evidence
30 Sep 2018
13F
Lead comparable stake: 12%
Showing 1-6 of 15 holder rows.
Quick read
Southpoint Capital Advisors LP leads the comparable SEC ownership view at 12%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Southpoint Capital Advisors LP's linked filing trail.
Comparable ownership
Top 5
Southpoint Capital Advisors LP
12%
Avoro Capital Advisors LLC
3%
Opaleye Management Inc.
2.8%
683 Capital Management, LLC
2.8%
EVENTIDE ASSET MANAGEMENT, LLC
2.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Southpoint Capital Advisors LP |
13F
Company
|
12%
|
$32,777,000
3,997,214 shares
|
— | 30 Sep 2018 |
| Avoro Capital Advisors LLC |
13F
Company
|
3%
|
$8,386,000
1,022,666 shares
|
— | 30 Sep 2018 |
| Opaleye Management Inc. |
13F
Company
|
2.8%
|
$7,995,000
975,000 shares
|
— | 30 Sep 2018 |
| 683 Capital Management, LLC |
13F
Company
|
2.8%
|
$7,965,000
971,351 shares
|
— | 30 Sep 2018 |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
Company
|
2.1%
|
$6,078,000
741,175 shares
|
— | 30 Sep 2018 |
| BlackRock Finance, Inc. |
13F
Company
|
1.6%
|
$4,590,000
559,787 shares
|
— | 30 Sep 2018 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2018
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
45
Shares
9,742,725
Rows available
45
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2018 vs Q3 2018 Across Filers
Q3 2018 holders
45
Q4 2018 holders
45
Holder diff
0
| Investor | Q3 2018 Shares | Q4 2018 Shares | Share Diff | Share Chg % | Q3 2018 value | Q4 2018 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend